Political News and Conservative Analysis About Congress, the President, and the Federal Government
, to tirzepatide, the active ingredient in Eli Lilly’s Mounjaro and Zepbound. Researchers found that patients on tirzepatide lost substantially more weight than those on semaglutide, sending ripples through the market.had fallen by nearly 3 points, about 2%, and they further fell by more than 2% by noon. By contrast,Both semaglutide and tirzepatide belong to the same new drug class of GLP-1s, each mimicking a natural hormone that curbs appetite and creates a feeling of fullness.
Zepbound, Lilly’s branding of tirzepatide for obesity management, was approved by the Food and Drug Administration in late 2023, making head-to-head comparison between the two drugs challenging., researchers examined the health records of more than 41,000 patients, nearly 32,000 of whom were on semaglutide either for obesity management or Type 2 diabetes treatment.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Intel, Nvidia, Eli Lilly rise premarket; BP, Novo Nordisk fallIntel, Nvidia, Eli Lilly rise premarket; BP, Novo Nordisk fall
Read more »
Broadcom, Eli Lilly and Trump Media rise premarket; Under Armour fallsBroadcom, Eli Lilly and Trump Media rise premarket; Under Armour falls
Read more »
Microsoft and Eli Lilly are among the most overbought stocks as the first half endsThese are Wall Street's most overbought stocks.
Read more »
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Read more »
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Read more »
DuPont draws suitors for its water unit, plus what's driving Eli Lilly's bounceThe Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.
Read more »